Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MRI Clues Help Distinguish Neuromyelitis Optica From MS
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
PEGylated Interferon May Boost Efficacy, Reduce Side Effects
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Leptin and other adipokines in EAE and MS
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
A rare case of SPG11 mutation with multiple sclerosis.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Episode 78 with Dr. Dessa Sadovnick on need for a pregnancy registry in MS
The relationship between static posturography measures and specific cognitive domains in individuals with multiple sclerosis.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI).
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
Papers: 5 Feb 2016 - 12 Feb 2016
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »